Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | SRC | P12931 | 1/20 | 0.31 |
| ▸ | LTK | P29376 | 1/20 | 0.30 |
| ▸ | CSNK1A1 | P48729 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18914364 | 0.82 | ALDH1A1 (0.39) | ALDH1A1MEN1MAPTKMT2ANPSR1 | |
| SCHEMBL29604216 | 0.82 | ALDH1A1 (0.50) | ALDH1A1MEN1MAPTKMT2ANPSR1 | |
| SCHEMBL13259513 | 0.76 | ALDH1A1 (0.36) | ALDH1A1 | |
| SCHEMBL24060674 | 0.76 | TDP1 (0.46) | ALDH1A1MEN1MAPTKMT2AGAA | |
| SCHEMBL24440488 | 0.71 | ALDH1A1 (0.38) | ALDH1A1NPSR1GAA | |
| SCHEMBL24950942 | 0.71 | TDP1 (0.41) | ALDH1A1NPSR1GAALTKCSNK1A1 | |
| SCHEMBL13620532 | 0.68 | ALDH1A1 (0.40) | ALDH1A1MEN1MAPTKMT2AGAA | |
| SCHEMBL14422045 | 0.68 | ALDH1A1 (0.35) | ALDH1A1NPSR1GAASRC | |
| SCHEMBL3437734 | 0.67 | ALDH1A1 (0.42) | ALDH1A1MEN1MAPTKMT2AGAA | |
| SCHEMBL13259498 | 0.67 | ALDH1A1 (0.41) | ALDH1A1MEN1MAPTKMT2ANPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7763727-B2 | Compound and organic electronic device using the same | MITSUI CHEMICALS, INC. (JP) | 2010-07-27 | — | — | US | disclosed |
| US-7763727-B2 | Compound and organic electronic device using the same | MITSUI CHEMICALS, INC. (JP) | 2010-07-27 | — | — | US | disclosed |
| US-20070219375-A1 | Novel Compound and Organic Electronic Device Using the Same | MITSUI CHEMICALS, INC. (JP) | 2007-09-20 | — | — | US | disclosed |
| US-20070219375-A1 | Novel Compound and Organic Electronic Device Using the Same | MITSUI CHEMICALS, INC. (JP) | 2007-09-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070219375-A1 | Novel Compound and Organic Electronic Device Using the Same | OR10J3, RPS10, NOX4 | ALDH1A1 1416/4885MEN1 2327/4885MAPT 2681/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.